Drug | Adverse event | n | ROR | 95% CI |
---|---|---|---|---|
CAM | Infections and infestations | 13 | 4.13 | 2.3–7.44 |
Blood and lymphatic system disorders | 12 | 1.95 | 1.06–3.58 | |
Hepatobiliary disorders | 11 | 2.61 | 1.39–4.91 | |
Gastrointestinal disorders | 10 | 1.5 | 0.78–2.89 | |
Respiratory, thoracic, and mediastinal disorders | 8 | 1.41 | 0.68–2.92 | |
Immune system disorders | 6 | 2.38 | 1.04–5.44 | |
Metabolism and nutrition disorders | 5 | 1.8 | 0.73–4.44 | |
EB | Eye disorders | 62 | 215.79 | 132.62–351.12 |
Nervous system disorders | 10 | 1.42 | 0.73–2.75 | |
RFP | Renal and urinary disorders | 9 | 7.03 | 3.35–14.77 |
Investigations | 8 | 6.99 | 3.22–15.18 | |
Blood and lymphatic system disorders | 5 | 1.81 | 0.71–4.62 |